Ramos-Martinez, AntonioParra-Ramirez, Lina MarcelaMorras, IgnacioCarnevali, MaríaJimenez-Ibañez, LorenaRubio-Rivas, ManuelArnalich, FranciscoBeato, Jose LuisMonge, DanielAsin, UxuaSuarez, CarmenFreire, Santiago JesusMendez-Bailon, ManuelPerales, IsabelLoureiro-Amigo, JoseGomez-Belda, Ana BelenPesqueira, Paula MariaGomez-Huelgas, RicardoMella, CarmenDiez-García, Luis FelipeFernandez-Sola, JoaquimGonzalez-Ferrer, RuthAroza, MarinaAnton-Santos, Juan MiguelLumbreras-Bermejo, Carlos2023-02-092023-02-092021-07-02Ramos-Martínez A, Parra-Ramírez LM, Morrás I, Carnevali M, Jiménez-Ibañez L, Rubio-Rivas M, et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci Rep. 2021 Jul 2;11(1):13733http://hdl.handle.net/10668/18150To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 patients were admitted to hospitals participating in the SEMI-COVID-19 network. 298 patients (4.2%) out of 7137 patients were readmitted after being discharged. 1541 (17.7%) died during the index admission and 35 died during hospital readmission (11.7%, p = 0.007). The median time from discharge to readmission was 7 days (IQR 3-15 days). The most frequent causes of hospital readmission were worsening of previous pneumonia (54%), bacterial infection (13%), venous thromboembolism (5%), and heart failure (5%). Age [odds ratio (OR): 1.02; 95% confident interval (95% CI): 1.01-1.03], age-adjusted Charlson comorbidity index score (OR: 1.13; 95% CI: 1.06-1.21), chronic obstructive pulmonary disease (OR: 1.84; 95% CI: 1.26-2.69), asthma (OR: 1.52; 95% CI: 1.04-2.22), hemoglobin level at admission (OR: 0.92; 95% CI: 0.86-0.99), ground-glass opacification at admission (OR: 0.86; 95% CI:0.76-0.98) and glucocorticoid treatment (OR: 1.29; 95% CI: 1.00-1.66) were independently associated with hospital readmission. The rate of readmission after hospital discharge for COVID-19 was low. Advanced age and comorbidity were associated with increased risk of readmission.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/GlucocorticoidsHemoglobinsBacterial InfectionsHeart FailureCOVID‑19Age FactorsAgedAged, 80 and overCOVID-19FemaleHumansMaleMiddle AgedPatient DischargePatient ReadmissionRetrospective StudiesRisk FactorsSARS-CoV-2research article34215803open accessReadmisión del PacienteInsuficiencia CardíacaGlucocorticoidesTromboembolia VenosaEnfermedad Pulmonar Obstructiva CrónicaInfecciones Bacterianas10.1038/s41598-021-93076-02045-2322PMC8253752https://www.nature.com/articles/s41598-021-93076-0.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253752/pdf